Literature DB >> 13402115

[Studies in search of new tuberculostatic drugs. I. Hydrazine derivatives, carbolic acid, phenols, quaternary ammonium compounds and their intermediaries].

E JENEY, T ZSOLNAI.   

Abstract

Entities:  

Keywords:  ANTISEPTICS, QUATERNARY AMMONIUM/effects; HYDRAZINE/related compounds; MYCOBACTERIUM TUBERCULOSIS/effect of drugs on

Mesh：

Substances：

Year:  1956        PMID： 13402115

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Orig        ISSN： 0372-8110


× No keyword cloud information.
  4 in total

1.  Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.

Authors:  Isaac M Westwood; Sanjib Bhakta; Angela J Russell; Elizabeth Fullam; Matthew C Anderton; Akane Kawamura; Andrew W Mulvaney; Richard J Vickers; Veemal Bhowruth; Gurdyal S Besra; Ajit Lalvani; Stephen G Davies; Edith Sim
Journal:  Protein Cell       Date:  2010-03-18       Impact factor: 14.870

2.  Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages.

Authors:  Areej Abuhammad; Elizabeth Fullam; Edward D Lowe; David Staunton; Akane Kawamura; Isaac M Westwood; Sanjib Bhakta; Alun Christopher Garner; David L Wilson; Peter T Seden; Stephen G Davies; Angela J Russell; Elspeth F Garman; Edith Sim
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

3.  Identification of the anti-mycobacterial functional properties of piperidinol derivatives.

Authors:  Collette S Guy; Esther Tichauer; Gemma L Kay; Daniel J Phillips; Trisha L Bailey; James Harrison; Christopher M Furze; Andrew D Millard; Matthew I Gibson; Mark J Pallen; Elizabeth Fullam
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

4.  Exploration of piperidinols as potential antitubercular agents.

Authors:  Areej Abuhammad; Elizabeth Fullam; Sanjib Bhakta; Angela J Russell; Garrett M Morris; Paul W Finn; Edith Sim
Journal:  Molecules       Date:  2014-10-10       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.